Thus, the imbalance of TGF-β/Smad signaling may be a major cause of renal fibrosis and rebalancing this pathway by inactivating Smad3 while upregulating Smad7 may produce a better therapeutic effect on renal fibrosis. The gene discussed is TGFB1; the disease is renal fibrosis.